In a report released on March 7, Puneet Souda from SVB Securities maintained a Buy rating on 908 Devices (MASS – Research Report), with a price target of $20.00. The company’s shares closed yesterday at $9.00.
Souda covers the Healthcare sector, focusing on stocks such as Natera, Exact Sciences, and Hologic. According to TipRanks, Souda has an average return of -7.6% and a 42.47% success rate on recommended stocks.
Currently, the analyst consensus on 908 Devices is a Moderate Buy with an average price target of $14.00.
See Insiders’ Hot Stocks on TipRanks >>
The company has a one-year high of $26.00 and a one-year low of $6.87. Currently, 908 Devices has an average volume of 258.9K.
Based on the recent corporate insider activity of 53 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MASS in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, industrial biotech, forensics and adjacent markets.
Read More on MASS:
